Mujeebat Bashiru Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

Last publication 2025 Last refreshed 2026-05-16

faculty

7 h-index 19 pubs 283 cited

Biography and Research Information

OverviewAI-generated summary

Mujeebat Bashiru's research focuses on the development and application of nanomedicines for cancer therapy, particularly combined chemo-phototherapy. Her work investigates cationic porphyrin-based ionic nanomedicines for photodynamic therapy and doxorubicin-based ionic nanomedicines for combined chemo-phototherapy. Bashiru also explores the role of cellular processes, such as endocytosis and organelle trafficking, in the efficacy of these nanomedicines. Her research interests extend to fluorescent chemical sensors, carbon-based catalysts, and spectroscopic methods for detection and diagnosis. Bashiru has a publication record including work on microplastics detection and Raman spectroscopy in biomedical research. She has collaborated with researchers at the University of Arkansas at Little Rock and Arkansas State University on multiple publications.

Metrics

  • h-index: 7
  • Publications: 19
  • Citations: 283

Selected Publications

  • Design and Discovery of New HIV‐1 RT Inhibitors Using Generative AI, Virtual Screening, and Molecular Dynamics Simulations (2025)
  • Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
    1 citation DOI OpenAlex
  • De novo design and bioactivity prediction of mitotic kinesin Eg5 inhibitors using MPNN and LSTM-based transfer learning (2025)
    4 citations DOI OpenAlex
  • In silico identification of potential HDAC3 inhibitors through machine learning, molecular docking, and molecular dynamics simulations for drug repurposing (2025)
    2 citations DOI OpenAlex
  • De Novo Design and Bioactivity Prediction of Mitotic Kinesin Eg5 Inhibitors Using MPNN and LSTM-Based Transfer Learning (2025)
  • IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
  • Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024)
    6 citations DOI OpenAlex
  • Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods (2024)
    22 citations DOI OpenAlex
  • Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
    8 citations DOI OpenAlex
  • Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy (2023)
    7 citations DOI OpenAlex
  • Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria (2023)
    1 citation DOI OpenAlex
  • FRET-based carbazole-fluorescein ionic nanoparticle for use as an effective bioimaging agent (2023)
  • Review of: "Determining kinetics parameters of bovine serum albumin-protected gold nanozymes toward different substrates" (2023)
  • Fluorescent chemical sensors: applications in analytical, environmental, forensic, pharmaceutical, biological, and biomedical sample measurement, and clinical diagnosis (2023)
    136 citations DOI OpenAlex
  • Recent Advancements in the Synthesis and Application of Carbon-Based Catalysts in the ORR (2021)
    38 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

76 Collaborators 32 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics